GenPath Raises $15.5M In Series A To Study Cancer Genes, Pathways May 20, 2002 By Karen Young No Comments
Trimeris Plans Filing Based On Positive T-20 Phase III Results May 17, 2002 By Karen Young No Comments
Deltagen Raises $25.3M Privately To Push Internal Drug Discovery May 17, 2002 By Karen Young No Comments
Trimeris Plans Filing Based On Positive T-20 Phase III Results May 17, 2002 By Karen Young No Comments
Deltagen Raises $25.3M Privately To Push Internal Drug Discovery May 17, 2002 By Karen Young No Comments
Emisphere's Oral Heparin Fails In Phase III Against Lovenox May 15, 2002 By Karen Young No Comments Emisphere Technologies Inc. said Tuesday that its Phase III trial of oral heparin failed to show superiority to Aventis SA's injected Lovenox in preventing deep-vein thrombosis in patients undergoing total hip replacement surgery. (BioWorld Today)Read More
